SearcharxivSearch

arXiv subjects

Luisa Bernardinelli

Publications and source records attributed to Luisa Bernardinelli.

4 recordsLinked to original sources

Mendelian Randomization with Incomplete Exposure Data: a Bayesian Approach

We expand Mendelian Randomization (MR) methodology to deal with randomly missing data on either the exposure or the outcome variable, and furthermore with data from nonindependent individuals (eg components of a family). Our method rests on the Bayesian MR framework proposed by Berzuini et al (2018), which we apply in a study of multiplex Multiple Sclerosis (MS) Sardinian families to characterise the role of certain plasma proteins in MS causation. The method is robust to presence of pleiotropic effects in an unknown number of instruments, and is able to incorporate inter-individual kinship information. Introduction of missing data allows us to overcome the bias introduced by the (reverse) effect of treatment (in MS cases) on level of protein. From a substantive point of view, our study results confirm recent suspicion that an increase in circulating IL12A and STAT4 protein levels does not cause an increase in MS risk, as originally believed, suggesting that these two proteins may not be suitable drug targets for MS.

stat.AP

Bayesian Mendelian Randomization identifies disease causing proteins via pedigree data, partially observed exposures and correlated instruments

Background In a study performed on multiplex Multiple Sclerosis (MS) Sardinian families to identify disease causing plasma proteins, application of Mendelian Randomization (MR) methods encounters difficulties due to relatedness of individuals, correlation between finely mapped genotype instrumental variables (IVs) and presence of missing exposures. Method We specialize the method of Berzuini et al (2018) to deal with these difficulties. The proposed method allows pedigree structure to enter the specification of the outcome distribution via kinship matrix, and treating missing exposures as additional parameters to be estimated from the data. It also acknowledges possible correlation between instruments by replacing the originally proposed independence prior for IV-specific pleiotropic effect with a g-prior. Based on correlated (r2< 0.2) IVs, we analysed the data of four candidate MS-causing proteins by using both the independence and the g-prior. Results 95% credible intervals for causal effect for proteins IL12A and STAT4 lay within the strictly negative real semiaxis, in both analyses, suggesting potential causality. Those instruments whose estimated pleiotropic effect exceeded 85% of total effect on outcome were found to act in trans. Analysis via frequentist MR gave inconsistent results. Replacing the independence with a g-prior led to smaller credible intervals for causal effect. Conclusions Bayesian MR may be a good way to study disease causation at a protein level based on family data and moderately correlated instruments.

stat.AP

Bayesian Mendelian Randomization

Our Bayesian approach to Mendelian Randomisation uses multiple instruments to assess the putative causal effect of an exposure on an outcome. The approach is robust to violations of the (untestable) Exclusion Restriction condition, and hence it does not require instruments to be independent of the outcome conditional on the exposure and on the confounders of the exposure-outcome relationship. The Bayesian approach offers a rigorous handling of the uncertainty (e.g. about the estimated instrument-exposure associations), freedom from asymptotic approximations of the null distribution and the possibility to elaborate the model in any direction of scientific relevance. We illustrate the last feature with the aid of a study of the metabolic mediators of the disease-inducing effects of obesity, where we elaborate the model to investigate whether the causal effect of interest interacts with a covariate. The proposed model contains a vector of unidentifiable parameters, $β$, whose $j$th element represents the pleiotropic (i.e., not mediated by the exposure) component of the association of instrument $j$ with the outcome. We deal with the incomplete identifiability by assuming that the pleiotropic effect of some instruments is null, or nearly so, formally by imposing on $β$ Carvalho's horseshoe shrinkage prior, in such a way that different components of $β$ are subjected to different degrees of shrinking, adaptively and in accord with the compatibility of each individual instrument with the hypothesis of no pleiotropy. This prior requires a minimal input from the user. We present the results of a simulation study into the performance of the proposed method under different types of pleiotropy and sample sizes. Comparisons with the performance of the weighted median estimator are made. Choice of the prior and inference via Markov chain Monte Carlo are discussed.

math.ST

Direct genetic effects and their estimation from matched case-control data

In genetic association studies, a single marker is often associated with multiple, correlated phenotypes (e.g., obesity and cardiovascular disease, or nicotine dependence and lung cancer). A pervasive question is then whether that marker has independent effects on all phenotypes. In this article, we address this question by assessing whether there is a direct genetic effect on one phenotype that is not mediated through the other phenotypes. In particular, we investigate how to identify and estimate such direct genetic effects on the basis of (matched) case-control data. We discuss conditions under which such effects are identifiable from the available (matched) case-control data. We find that direct genetic effects are sometimes estimable via standard regression methods, and sometimes via a more general G-estimation method, which has previously been proposed for random samples and unmatched case-control studies (Vansteelandt, 2009) and is here extended to matched case-control studies. The results are used to assess whether the FTO gene is associated with myocardial infarction other than via an effect on obesity.

stat.ME